pI: 4.8331 |
Length (AA): 1064 |
MW (Da): 118278 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
32 | 222 | 5cwn (A) | 7 | 200 | 16.00 | 0.017 | 0.04 | 0.345311 | -0.67 |
311 | 389 | 5hmo (A) | 812 | 890 | 33.00 | 0.0025 | 0.02 | 0.550948 | -1.72 |
651 | 718 | 3geh (A) | 199 | 275 | 44.00 | 0.16 | 0.99 | 0.43861 | 0.27 |
669 | 721 | 3a1s (A) | 19 | 72 | 47.00 | 0.29 | 0.84 | 0.538512 | 0.08 |
671 | 712 | 4dcu (A) | 180 | 230 | 50.00 | 0.29 | 0.58 | 0.493174 | 0.27 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 Tachyzoite, ME49 Bradyzoite. | Gregory Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | VEG Tachyzoite, ME49 merozoite, ME49 Oocyst. | Gregory Hehl AB Fritz HM |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Sibley/Greg | ToxoDB |
Gregory | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_127871)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G08410 | P-loop containing nucleoside triphosphate hydrolases superfamily protein |
Arabidopsis thaliana | AT2G27200 | P-loop containing nucleoside triphosphate hydrolase-like protein |
Babesia bovis | BBOV_IV010460 | GTPase subfamily protein |
Brugia malayi | Bm1_28980 | hypothetical protein |
Candida albicans | CaO19.10967 | growth, morphology, mating, sporulation |
Candida albicans | CaO19.3463 | growth, morphology, mating, sporulation |
Caenorhabditis elegans | CELE_C53H9.2 | Protein C53H9.2, isoform C |
Cryptosporidium hominis | Chro.20436 | GTP-binding protein |
Cryptosporidium parvum | cgd2_4090 | YawG/Kre35p-like, Yjeq GTpase |
Dictyostelium discoideum | DDB_G0294292 | unclassified GTPase |
Drosophila melanogaster | Dmel_CG14788 | Nucleostemin ortholog (H. sapiens) 3 |
Echinococcus granulosus | EgrG_000219400 | GTP binding protein HSR1 |
Entamoeba histolytica | EHI_118800 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000219400 | GTP binding protein, HSR1 |
Giardia lamblia | GL50803_15867 | GTP-binding protein |
Homo sapiens | ENSG00000041802 | large 60S subunit nuclear export GTPase 1 |
Leishmania braziliensis | LbrM.05.0200 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_050200.1 | 50S ribosome-binding GTPase, putative |
Leishmania infantum | LinJ.05.0200 | hypothetical protein, conserved |
Leishmania major | LmjF.05.0200 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.05.0200 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_08056 | hypothetical protein |
Mus musculus | 224092 | large subunit GTPase 1 homolog (S. cerevisiae) |
Neospora caninum | NCLIV_003130 | GTP-binding protein, related |
Oryza sativa | 4333574 | Os03g0647500 |
Oryza sativa | 4352809 | Os12g0618300 |
Onchocerca volvulus | OVOC73 | Large subunit GTPase 1 homolog |
Plasmodium berghei | PBANKA_1013500 | large subunit GTPase 1, putative |
Plasmodium falciparum | PF3D7_1431300 | large subunit GTPase 1, putative |
Plasmodium knowlesi | PKNH_1327400 | large subunit GTPase 1, putative |
Plasmodium vivax | PVX_084975 | hypothetical protein, conserved |
Plasmodium yoelii | PY06180 | unnamed protein product |
Saccharomyces cerevisiae | YGL099W | putative GTPase LSG1 |
Schistosoma japonicum | Sjp_0021210 | ko:K06948 GTP-binding protein MMR1, putative |
Schistosoma mansoni | Smp_147850 | GTP-binding protein-related |
Schmidtea mediterranea | mk4.006673.01 | GTP-binding protein-related |
Schmidtea mediterranea | mk4.006673.02 | |
Schmidtea mediterranea | mk4.008284.01 | |
Trypanosoma brucei gambiense | Tbg972.5.5820 | GTP-binding protein, putative |
Trypanosoma brucei | Tb927.5.4310 | GTP-binding protein, putative |
Trypanosoma congolense | TcIL3000_5_4930 | GTP-binding protein, putative |
Trypanosoma cruzi | TcCLB.510351.70 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.507601.90 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_208490 | hypothetical protein |
Theileria parva | TP01_0681 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_248980 | mmr1/hsr1 GTP binding protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.4310 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.4310 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.4310 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.4310 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C53H9.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C53H9.2 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C53H9.2 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C53H9.2 | Caenorhabditis elegans | sterile | wormbase |
YGL099W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1013500 | Plasmodium berghei | Essential | plasmo |
TGME49_208490 this record | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.3